Published in Food and Drug Law Weekly, July 30th, 2004
The study will take place under the direction of David J. Stewart, MD, professor in the Department of Thoracic/Head and Neck Medical Oncology at The University of Texas M.D. Anderson Cancer Center in Houston.
Vascular targeting is a novel approach to cancer treatment, said David Stewart, Principal Investigator for the study....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.